Guojun Zhang

AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon–Small-Cell Lung Cancer With <i>EGFR</i> Exon 19 Deletion or L858R Mutations

Shun Lü, Xiaorong Dong, Hong Jian et al. · Journal of Clinical Oncology · 2022 · 279 citations · Full text

Medicine, Oncology, Pharmacology +16

Efficacy of Aumolertinib (HS-10296) in Patients With Advanced EGFR T790M+ NSCLC: Updated Post-National Medical Products Administration Approval Results From the APOLLO Registrational Trial

Shun Lü, Qiming Wang, Guojun Zhang et al. · Journal of Thoracic Oncology · 2021 · 143 citations · Full text

Medicine, Oncology, Pharmacology +11

MiR-144 Inhibits Proliferation and Induces Apoptosis and Autophagy in Lung Cancer Cells by Targeting TIGAR

Shanshan Chen, Ping Li, Juan Li et al. · Cellular Physiology and Biochemistry · 2015 · 116 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Knockdown of LncRNA MALAT1 contributes to the suppression of inflammatory responses by up-regulating miR-146a in LPS-induced acute lung injury

Lingling Dai, Guojun Zhang, Zhe Cheng et al. · Connective Tissue Research · 2018 · 111 citations

Veterinary Medicine, Immunology, Molecular Biology +17

MiRNA-192-5p attenuates airway remodeling and autophagy in asthma by targeting MMP-16 and ATG7

Li‐Li Lou, Mengyuan Tian, Jingxia Chang et al. · Biomedicine & Pharmacotherapy · 2019 · 103 citations · Full text

Life Sciences, Cell Biology, Molecular Medicine +17